Cite
Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR-dependent pathway.
MLA
Liu, Liang, et al. “Amphiregulin Enhances Cardiac Fibrosis and Aggravates Cardiac Dysfunction in Mice with Experimental Myocardial Infarction Partly through Activating EGFR-Dependent Pathway.” Basic Research in Cardiology, vol. 113, no. 2, Mar. 2018, p. 0. EBSCOhost, https://doi.org/10.1007/s00395-018-0669-y.
APA
Liu, L., Jin, X., Hu, C.-F., Zhang, Y.-P., Zhou, Z., Li, R., & Shen, C.-X. (2018). Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR-dependent pathway. Basic Research in Cardiology, 113(2), 0. https://doi.org/10.1007/s00395-018-0669-y
Chicago
Liu, Liang, Xian Jin, Cui-Fen Hu, Ya-Ping Zhang, Zhong’e Zhou, Rong Li, and Cheng-Xing Shen. 2018. “Amphiregulin Enhances Cardiac Fibrosis and Aggravates Cardiac Dysfunction in Mice with Experimental Myocardial Infarction Partly through Activating EGFR-Dependent Pathway.” Basic Research in Cardiology 113 (2): 0. doi:10.1007/s00395-018-0669-y.